- Sun Pharma Distributors recalled several eye drop brands due to contamination concerns
- Distributors were instructed to stop sales and return all remaining stock immediately
- Affected brands include Brinolar, Lotepred, Nepalact OD, Depopred, Brinzotim, Nepalact-Z, Toba-F
Sun Pharma Distributors Ltd has reportedly recalled several eye drop brands from the market over contamination concerns, asking distributors to immediately stop sales and return all remaining stock.
According to a July 17 letter accessed by ANI, the company instructed distributors to halt billing and withdraw the affected products as a precaution. The recall covers several ophthalmic brands, including Brinolar, Lotepred, Nepalact OD, Depopred, Brinzotim, Nepalact-Z and Toba-F.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
ALSO READ: Medicines, Misleading Ads On Tukaram Mundhe's Radar? Maharashtra FDA Chief Says...
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
The company has issued instructions to distributors through a letter, according to ANI: “In this regard, you are requested to immediately cease billing of the above-mentioned product and provide us details of any stock currently held by you.”
It further stated, "Further, you are requested to send back to us any stocks of the product available with you, as well as those received from any sources, on priority."
Increased scrutiny of pharmaceutical manufacturing
Sun Pharma said it has recalled certain eye drop products in India following contamination concerns, as scrutiny over the safety and quality of ophthalmic medicines increases.
The company has assured consumers that patient safety remains its highest priority and said it is taking necessary measures to address the issue.
Focus on strengthening quality assurance
Authorities and industry experts have emphasised that consistent monitoring, improved manufacturing processes and strict adherence to safety protocols are essential to protect consumers, according to ANI.
ALSO READ: Saving The Yen: Why Is US Backing Japan's Currency Rescue Mission? Explained
Experts have warned that contaminated or unsafe eye drops can pose serious health risks, including eye infections and potential vision damage. Unlike many other medicines, eye drops are applied directly to the eyes, making sterility a critical requirement and contamination a major concern.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
